Advisor Group Holdings, Inc. Bicycle Therapeutics PLC Transaction History

Advisor Group Holdings, Inc.

  • $42.1 Billion
  • Q1 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 18 shares of BCYC stock, worth $153. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18
Previous 1,042 98.27%
Holding current value
$153
Previous $14,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$8.49 - $15.16 $8,693 - $15,523
-1,024 Reduced 98.27%
18 $0
Q3 2024

Nov 13, 2024
SELL
$19.58 - $27.24 $4,248 - $5,911
-217 Reduced 17.24%
1,042 $23,000
Q2 2024

Aug 13, 2024
SELL
$20.02 - $24.69 $2,602 - $3,209
-130 Reduced 9.36%
1,259 $25,000
Q1 2024

May 10, 2024
SELL
$16.75 - $26.1 $9,949 - $15,503
-594 Reduced 29.95%
1,389 $34,000
Q4 2023

Feb 12, 2024
SELL
$13.29 - $22.2 $18,140 - $30,303
-1,365 Reduced 40.77%
1,983 $35,000
Q3 2023

Nov 13, 2023
BUY
$19.9 - $26.25 $20,457 - $26,985
1,028 Added 44.31%
3,348 $67,000
Q2 2023

Aug 10, 2023
BUY
$18.95 - $28.67 $23,877 - $36,124
1,260 Added 118.87%
2,320 $59,000
Q1 2023

May 12, 2023
SELL
$20.02 - $31.37 $5,005 - $7,842
-250 Reduced 19.08%
1,060 $22,000
Q4 2022

Feb 10, 2023
SELL
$20.37 - $32.9 $2,037 - $3,290
-100 Reduced 7.09%
1,310 $38,000
Q3 2022

Nov 14, 2022
BUY
$17.49 - $28.44 $8,045 - $13,082
460 Added 48.42%
1,410 $33,000
Q2 2022

Aug 10, 2022
SELL
$12.95 - $46.99 $40,002 - $145,152
-3,089 Reduced 76.48%
950 $16,000
Q1 2022

May 04, 2022
SELL
$40.12 - $59.5 $41,123 - $60,987
-1,025 Reduced 20.24%
4,039 $176,000
Q3 2021

Nov 05, 2021
SELL
$27.95 - $44.24 $367,039 - $580,959
-13,132 Reduced 72.17%
5,064 $210,000
Q2 2021

Aug 02, 2021
BUY
$27.0 - $32.28 $69,363 - $82,927
2,569 Added 16.44%
18,196 $552,000
Q1 2021

May 13, 2021
SELL
$19.12 - $30.25 $123,993 - $196,171
-6,485 Reduced 29.33%
15,627 $467,000
Q4 2020

Feb 10, 2021
SELL
$17.95 - $21.36 $71,584 - $85,183
-3,988 Reduced 15.28%
22,112 $397,000
Q3 2020

Nov 12, 2020
SELL
$15.3 - $20.8 $122,400 - $166,400
-8,000 Reduced 23.46%
26,100 $497,000
Q2 2020

Aug 14, 2020
BUY
$12.63 - $18.21 $429,420 - $619,140
34,000 Added 34000.0%
34,100 $537,000
Q1 2020

May 18, 2020
BUY
$9.82 - $18.0 $982 - $1,800
100 New
100 $1,000

Others Institutions Holding BCYC

# of Institutions
101
Shares Held
42.8M
Call Options Held
15.6K
Put Options Held
27.7K
View Full List

About BICYCLE THERAPEUTICS plc

BCYC Quotes by TradingView
  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $254M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email